Brief: Santen Pharmaceutical - Announces U.S. FDA Acceptance Of Premarket Approval (Pma) Application For De-128 (Microshunt) For Review

SANTEN PHARMACEUTICAL

07/07/2020 24:43

July 7 (Reuters) - Santen Pharmaceutical Co Ltd  4536.T :
    * SANTEN PHARMACEUTICAL CO LTD - ANNOUNCES U.S. FDA
ACCEPTANCE OF
PREMARKET APPROVAL (PMA) APPLICATION FOR DE-128 (MICROSHUNT) FOR
REVIEW

Source text for Eikon:  ID:nTSSF6ff0d 
Further company coverage:  4536.T